-
Je něco špatně v tomto záznamu ?
Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus
Jana Vrbikova, Bela Bendlova, Marketa Vankova, Katerina Dvorakova, Tereza Grimmichova, Karel Vondra, Giovanni Pacini
Jazyk angličtina Země Velká Británie
Typ dokumentu práce podpořená grantem
Grantová podpora
NR7809
MZ0
CEP - Centrální evidence projektů
NS10342
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Medline Complete (EBSCOhost)
od 2003-10-01
ROAD: Directory of Open Access Scholarly Resources
od 1987
- MeSH
- analýza rozptylu MeSH
- beta-buňky fyziologie metabolismus MeSH
- C-reaktivní protein genetika metabolismus MeSH
- diabetes mellitus 2. typu genetika patofyziologie MeSH
- dospělí MeSH
- glukózový toleranční test MeSH
- index tělesné hmotnosti MeSH
- inzulin genetika metabolismus MeSH
- inzulinová rezistence genetika MeSH
- krevní glukóza genetika metabolismus MeSH
- lidé MeSH
- plocha pod křivkou MeSH
- syndrom polycystických ovarií genetika metabolismus patofyziologie MeSH
- testosteron metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
AIM: To study the impact of family history (FH) of type 2 diabetes mellitus on beta-cell compensatory mechanism in women with polycystic ovary syndrome (PCOS). SUBJECTS AND METHODS: A total of 70 women with PCOS, 14 with first-degree relative with type 2 diabetes mellitus (T2DM) (FH+), 56 with negative FH of T2DM (FH-) and 72 age and BMI matched control healthy women (CNT) underwent oral glucose tolerance test (OGTT). Insulin resistance was evaluated as oral glucose index (OGIS); insulin and C-peptide secretion as the insulinogenic index in 30th min of OGTT. RESULTS: Fasting blood glucose levels were significantly higher in FH+ than in FH- (p < 0.05). Fasting insulin was higher in FH+ than in CNT (p < 0.05). Fasting C-peptide was significantly higher in both FH- and FH+ than in CNT (p < 0.05 and p < 0.01, respectively). OGIS was lower in FH+ than in FH- or in CNT (p < 0.05). Insulinogenic index calculated from C-peptide values (II-Cp) was lower in FH+ than in CNT (p < 0.05). Adaptation index calculated from the values of OGIS and insulinogenic index was significantly lower in FH+ than in CNT or in FH- (p < 0.0001 and p < 0.01, respectively). CONCLUSIONS: Insulin resistance and defective early-phase insulin secretion is present only in those PCOS-affected subjects who had positive FH of T2DM.
Citace poskytuje Crossref.org
- 000
- 03470naa a2200577 a 4500
- 001
- bmc12008611
- 003
- CZ-PrNML
- 005
- 20141202141553.0
- 008
- 120316s2009 xxk eng||
- 009
- AR
- 024 __
- $a 10.1080/09513590902972133 $2 doi
- 035 __
- $a (PubMed)19572227
- 040 __
- $a ABA008 $b cze $d ABA008
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Vrbíková, Jana, $d 1964- $7 jo20000074106 $u Institute of Endocrinology, Prague, Czech Republic. jvrbikova@endo.cz
- 245 10
- $a Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus / $c Jana Vrbikova, Bela Bendlova, Marketa Vankova, Katerina Dvorakova, Tereza Grimmichova, Karel Vondra, Giovanni Pacini
- 520 9_
- $a AIM: To study the impact of family history (FH) of type 2 diabetes mellitus on beta-cell compensatory mechanism in women with polycystic ovary syndrome (PCOS). SUBJECTS AND METHODS: A total of 70 women with PCOS, 14 with first-degree relative with type 2 diabetes mellitus (T2DM) (FH+), 56 with negative FH of T2DM (FH-) and 72 age and BMI matched control healthy women (CNT) underwent oral glucose tolerance test (OGTT). Insulin resistance was evaluated as oral glucose index (OGIS); insulin and C-peptide secretion as the insulinogenic index in 30th min of OGTT. RESULTS: Fasting blood glucose levels were significantly higher in FH+ than in FH- (p < 0.05). Fasting insulin was higher in FH+ than in CNT (p < 0.05). Fasting C-peptide was significantly higher in both FH- and FH+ than in CNT (p < 0.05 and p < 0.01, respectively). OGIS was lower in FH+ than in FH- or in CNT (p < 0.05). Insulinogenic index calculated from C-peptide values (II-Cp) was lower in FH+ than in CNT (p < 0.05). Adaptation index calculated from the values of OGIS and insulinogenic index was significantly lower in FH+ than in CNT or in FH- (p < 0.0001 and p < 0.01, respectively). CONCLUSIONS: Insulin resistance and defective early-phase insulin secretion is present only in those PCOS-affected subjects who had positive FH of T2DM.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a analýza rozptylu $7 D000704
- 650 02
- $a plocha pod křivkou $7 D019540
- 650 02
- $a krevní glukóza $x genetika $x metabolismus $7 D001786
- 650 02
- $a index tělesné hmotnosti $7 D015992
- 650 02
- $a C-reaktivní protein $x genetika $x metabolismus $7 D002097
- 650 02
- $a diabetes mellitus 2. typu $x genetika $x patofyziologie $7 D003924
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a glukózový toleranční test $7 D005951
- 650 02
- $a lidé $7 D006801
- 650 02
- $a inzulin $x genetika $x metabolismus $7 D007328
- 650 02
- $a inzulinová rezistence $x genetika $7 D007333
- 650 02
- $a beta-buňky $x fyziologie $x metabolismus $7 D050417
- 650 02
- $a syndrom polycystických ovarií $x genetika $x metabolismus $x patofyziologie $7 D011085
- 650 02
- $a testosteron $x metabolismus $7 D013739
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bendlová, Běla, $d 1962- $7 jo20000074069 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vaňková, Markéta, $d 1974- $7 xx0140642 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Dvořáková, Kateřina $7 xx0070717 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Grimmichová, Tereza. $7 xx0229684 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vondra, Karel, $d 1943- $7 jo20000074105 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Pacini, Giovanni $u Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padova, Italy Read More: http://informahealthcare.com/doi/abs/10.1080/09513590902972133
- 773 0_
- $t Gynecological Endocrinology $p Gynecol Endocrinol $g Roč. 25, č. 9 (2009), s. 597-602 $w MED00008732 $x 0231-5882
- 773 0_
- $p Gynecol Endocrinol $g 25(9):597-602, 2009 Sep
- 910 __
- $a ABA008 $b x $y 4 $z 0
- 990 __
- $a 20120319124547 $b ABA008
- 991 __
- $a 20141202141545 $b ABA008
- 999 __
- $a ok $b bmc $g 901961 $s 765506
- BAS __
- $a 3
- BMC __
- $a 2009 $b 25 $c 9 $d 597-602 $m Gynecological endocrinology $x MED00008732
- GRA __
- $a NR7809 $p MZ0
- GRA __
- $a NS10342 $p MZ0
- LZP __
- $a 2012-1Q10/